Varamir
DeskNewsCalendarSaved
Sign in · build your desk
PURR

Hyperliquid Strategies Inc

Supply chain · Ownership · Earnings

OverviewSupply chainOwnershipNews
NewsCompanies A–ZMethodologySourcesCorrectionsTerms

Not investment advice. Not a broker-dealer. Prices: Intrinio (indices shown as ETF proxies). Supply-chain data CC BY 4.0; market data not redistributable.

Market
DeskNewsCalendarSaved
Reference
MethodologySourcesCorrectionsTerms
You
Theme
Sign in · build your desk
DeskNewsCalendarSaved
PURRHyperliquid Strategies Inc11.83▼ −5.36%
Earnings›Brief›

Changes

last 30 days
kindeventageactions
Sep 158-K8-KMaterial agreement: Amendment No. 3 to the ChEF Purchase Agreement with Chardan Capital Markets LLC.source3wsource
Sep 148-K8-KMaterial agreement: Amendment No. 2 to the ChEF Purchase Agreement with Chardan Capital Markets LLC.source3wsource

Who supplies Hyperliquid Strategies Inc, and who buys from it

Hyperliquid Strategies Inc has 4 disclosed suppliers and 1 disclosed customer in SEC filings.

Who supplies Hyperliquid Strategies Inc?

4 disclosed

4 disclosed: Guidant Bio Therapeutics Inc., Nexus Research Labs, Inc., Continental Stock Transfer & Trust Company and 1 more.

  1. 1—Guidant Bio Therapeutics Inc.
  2. 2—Nexus Research Labs, Inc.
  3. 3—Continental Stock Transfer & Trust Company
  4. 4—LifeSci Capital, LLC

Who buys from Hyperliquid Strategies Inc?

1 disclosed

1 disclosed: Chardan Capital Markets LLC.

  1. 1—Chardan Capital Markets LLC
PURR

Hyperliquid Strategies Inc

Supply chain · Ownership · Earnings

Finance Services

11.83
▲ +0.11 · +0.94%after closeafter hours
at close ▼ −0.78 · −6.24%
as of 23:47 UTC
open
12.33
volume
10.2M
mkt cap
$936.0M
p/e
3.65
eps
3.21
day range
11.67 – 12.33
11.83 sits 24 percent of the way through this range.
52-week
3.01 – 14.76
11.83 sits 75 percent of the way through this range.
next earningsAug 10 · in 306d · after closeafter close · est.
EarningsExpected move · positioning · linked exposure›Briefprint›

Intraday

▼ −4.06% since 4 AM
11.674 AM8 AM1 PM7 PMprepost
12.012.2prev11.7211.83

High 12.33 4:00 am · Low 11.67 3:00 pm ET

Sources

sec edgar · verbatim disclosure

Sources for PURR relationships

Show sources· 5›
  1. —Guidant Bio Therapeutics Inc.buys from›
    “In connection with the APA, we engaged Guidant under a transaction services agreement (the "TSA") to provide services to us for fees of $0.175 million, paid at the closing of the APA.”

    10-K0001193125-26-370281filed Aug 27 '26

  2. —Nexus Research Labs, Inc.buys from›
    “Under the Company's Validator Service Agreement with Unit, Unit controls the operation, maintenance, monitoring, and technical management of Validator Nodes and Platform on behalf of the Company.”

    10-K0001193125-26-370281filed Aug 27 '26

  3. —Chardan Capital Markets LLCsells to›
    “Pursuant to and upon the terms and subject to the conditions and limitations set forth in the Purchase Agreement, we have the right from time to time at our option to direct Chardan to purchase up to $1.0 billion of shares of our Common Stock.”

    10-K0001193125-26-370281filed Aug 27 '26

  4. —Continental Stock Transfer & Trust Companybuys from›
    “Also pursuant to the Transaction Agreement, at the Closing we entered into a Contingent Value Rights Agreement (the "CVR Agreement") with Continental Stock Transfer & Trust Company, as rights agent ("Rights Agent"), pursuant to which holders of shares of Sonnet common stock, excluding the shares of Sonnet common stock issued pursuant to the Closing PIPE, and in-the-money warrants, in each case, as of immediately prior to the Effective Time, received one CVR for each then-outstanding share of Sonnet common stock held by such stockholder (or, in the case of Sonnet in-the-money warrants, each share of Sonnet common stock for which such in-the-money warrants was exercisable into as of such date).”

    10-K0001193125-26-370281filed Aug 27 '26

  5. —LifeSci Capital, LLCbuys from›
    “The Company engaged LifeSci Capital, LLC as a qualified independent underwriter in connection with the Purchase Agreement.”

    10-K0001193125-26-370281filed Aug 27 '26

Supply chain

SEC · 5 direct ties

PURR (Hyperliquid Strategies Inc) has 4 disclosed suppliers and 1 disclosed customers, strongest disclosure first.

Suppliers:

  1. Guidant Bio Therapeutics Inc., price pending
  2. Nexus Research Labs, Inc., price pending
  3. Continental Stock Transfer & Trust Company, price pending
  4. LifeSci Capital, LLC, price pending

Customers:

  1. Chardan Capital Markets LLC, price pending
100%
expand

Distance from centre = disclosure strength · Extended: 2nd-degree ties, single companies only